0001209191-18-046244.txt : 20180810 0001209191-18-046244.hdr.sgml : 20180810 20180810164807 ACCESSION NUMBER: 0001209191-18-046244 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180809 FILED AS OF DATE: 20180810 DATE AS OF CHANGE: 20180810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Routti Jorma CENTRAL INDEX KEY: 0001621330 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 181009410 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS ST., CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-09 0 0000921299 FIBROGEN INC FGEN 0001621330 Routti Jorma C/O FIBROGEN, INC. 409 ILLINOIS ST. SAN FRANCISCO CA 94158 1 0 0 0 Common Stock 2018-08-09 4 M 0 6000 18.00 A 137540 D Common Stock 2018-08-09 4 S 0 3700 59.60 D 133840 D Common Stock 2018-08-09 4 S 0 2028 60.36 D 131812 D Common Stock 2018-08-09 4 S 0 272 61.21 D 131540 D Stock Option (Right to Buy) 18.00 2018-08-09 4 M 0 6000 0.00 D 2024-11-13 Common Stock 6000 0 D Shares sold pursuant to a 10b5-1 plan. The shares were sold at prices ranging from $59.10 to $60.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $60.10 to $60.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $61.10 to $61.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Fully vested. /s/ Dorothy Pacini, Attorney-in-fact 2018-08-10